Stabilitech wins LTF Environment Award

Stabilitech is Winner of the Environment Award in London Technology Fund Competition 2008

Stabilitech’s technology protects efficacy, reduces wastage and
saves energy

The London Technology Fund, London’s specialist investor in new
technology companies, yesterday announced the winners in the four
sectors of the London Technology Fund Competition 2008. The winners were selected from nine finalists and announced at an Awards Ceremony in London last night. The Awards were the culmination of an eight-month programme which started with nearly 150 applicants and involved 40 shortlisted companies in a programme of training and advice designed to help prepare for investment and build relationships with major technology
corporates. The special Environment Award, available to any sector, was won by the life science company Stabilitech, whose technology for vaccines is designed to protect efficacy, reduce wastage and save energy.

Stabilitech Ltd has developed a novel proprietary technology designed to stabilise live viral vaccines and other biological products - enabling stable storage over a wide range of temperatures. This means that vaccines incorporating the technology can be stored and transported without the need for end-to-end refrigeration. It will greatly reduce the significant
wastage of vaccines and biopharmaceuticals due to heat/freeze damage. The technology also will facilitate stockpiling of vaccines such as for pandemic influenza.

Dr Barbara Domayne-Hayman, Chief Executive Officer, said, "We are delighted to have won the Environment Award at the LTF competition awards ceremony last night. The competition programme was very well organised, with a wide variety of workshops covering key aspects of business for early stage companies. The 'speed dating' event, where we had the opportunity to meet major corporates and investors, was
particularly useful."

Ends//